News|Podcasts|October 25, 2022
Accelerating New Medicines: Innovation and Technology at Curia
Author(s)Curia
Curia is proud to partner with pharma and biotech companies to make new medicines that save lives. In order to be able to do that, Curia needs to be constantly innovating. In this podcast, you will learn from Curia’s VP of Portfolio and Sourcing, James Grabowski, about Curia’s small and large molecules most recent technologies, and capabilities.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Related Content
Trending on PharmExec
1
Pfizer Receives Unsolicited Mini-Tender Offer for 1 Million Shares from Tutanota: Report
2
Pharmaceutical Executive Daily: Pfizer Warns Shareholders to Reject Mini-Tender Offer
3
How Do Recent Actions from FDA Provide Insight to the Agency's Enforcement Posture?
4
Gilead Sciences Enters $2.1 Billion Definitive Agreement to Acquire Ouro Medicines
5